AU2003300535B2 - Imino acid derivatives for use as inhibitors of matrix metalloproteinases - Google Patents
Imino acid derivatives for use as inhibitors of matrix metalloproteinases Download PDFInfo
- Publication number
- AU2003300535B2 AU2003300535B2 AU2003300535A AU2003300535A AU2003300535B2 AU 2003300535 B2 AU2003300535 B2 AU 2003300535B2 AU 2003300535 A AU2003300535 A AU 2003300535A AU 2003300535 A AU2003300535 A AU 2003300535A AU 2003300535 B2 AU2003300535 B2 AU 2003300535B2
- Authority
- AU
- Australia
- Prior art keywords
- heteroaryl
- ring
- substituted
- independently
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10300015.1 | 2003-01-03 | ||
| DE10300015A DE10300015A1 (de) | 2003-01-03 | 2003-01-03 | Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen |
| PCT/EP2003/014611 WO2004060874A1 (de) | 2003-01-03 | 2003-12-19 | Iminosäurederivate als inhibitoren von matrix-metalloproteinasen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003300535A1 AU2003300535A1 (en) | 2004-07-29 |
| AU2003300535B2 true AU2003300535B2 (en) | 2009-12-17 |
Family
ID=32519590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003300535A Ceased AU2003300535B2 (en) | 2003-01-03 | 2003-12-19 | Imino acid derivatives for use as inhibitors of matrix metalloproteinases |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20050004166A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1585728B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4764009B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE458721T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003300535B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0317894A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2512346A1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE10300015A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1585728T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2341612T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL169496A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05006054A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1585728E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004060874A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
| DE102005015040A1 (de) * | 2005-03-31 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| CA2617055A1 (en) * | 2005-07-29 | 2007-02-08 | Bayer Healthcare Llc | Preparation and use of biphenyl amino acid derivatives for the treatment of obesity |
| MX2011000512A (es) * | 2008-07-14 | 2011-02-24 | Novartis Ag | Inhibidores selectivos de mmp-12 y mmp-13 basados en acido hidroxamico. |
| RU2646752C2 (ru) * | 2016-02-25 | 2018-03-07 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Ингибиторы цинк-зависимых металлопротеиназ (ММП-2 и ММП-9) в ряду бензоиламино(фенилсульфонил)-замещенных циклических аминокислот как потенциальные лекарственные средства, препятствующие постинфарктному ремоделированию левого желудочка сердца |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| IT1264447B1 (it) | 1993-05-14 | 1996-09-23 | Ist Naz Stud Cura Dei Tumori | Espressione di oncogeni derivati da ntrki in cellule di feocromocitoma pc12 ed utilizzo di questo sistema come screening di sostanze di |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| KR100266467B1 (ko) * | 1995-09-27 | 2000-10-02 | 우에노 도시오 | 설폰아미드 유도체 |
| TR199800849T2 (xx) * | 1995-11-13 | 1998-07-21 | Hoechst Aktiengesellschaft | Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri |
| WO2000058304A1 (en) * | 1999-03-26 | 2000-10-05 | Shionogi & Co., Ltd. | Heterocyclic sulfonamide derivatives |
| AR027943A1 (es) * | 2000-02-25 | 2003-04-16 | Wyeth Corp | Acidos orto-sulfonamido aril hidroxamicos como inhibidores de metaloproteinasa de matriz y preparacion de los mismos |
| US6855708B2 (en) | 2001-03-20 | 2005-02-15 | Merck & Co., Inc. | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
-
2003
- 2003-01-03 DE DE10300015A patent/DE10300015A1/de not_active Withdrawn
- 2003-12-19 AU AU2003300535A patent/AU2003300535B2/en not_active Ceased
- 2003-12-19 AT AT03814463T patent/ATE458721T1/de not_active IP Right Cessation
- 2003-12-19 PT PT03814463T patent/PT1585728E/pt unknown
- 2003-12-19 CA CA002512346A patent/CA2512346A1/en not_active Abandoned
- 2003-12-19 JP JP2004564205A patent/JP4764009B2/ja not_active Expired - Fee Related
- 2003-12-19 ES ES03814463T patent/ES2341612T3/es not_active Expired - Lifetime
- 2003-12-19 DE DE50312458T patent/DE50312458D1/de not_active Expired - Lifetime
- 2003-12-19 WO PCT/EP2003/014611 patent/WO2004060874A1/de not_active Ceased
- 2003-12-19 DK DK03814463.0T patent/DK1585728T3/da active
- 2003-12-19 MX MXPA05006054A patent/MXPA05006054A/es active IP Right Grant
- 2003-12-19 EP EP03814463A patent/EP1585728B1/de not_active Expired - Lifetime
- 2003-12-19 BR BR0317894-3A patent/BR0317894A/pt not_active IP Right Cessation
-
2004
- 2004-01-05 US US10/751,600 patent/US20050004166A1/en not_active Abandoned
-
2005
- 2005-06-30 IL IL169496A patent/IL169496A0/en unknown
-
2006
- 2006-04-18 US US11/405,834 patent/US7772270B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| D1: YE, et al., Journal of the Chemical Society, Perkin Transactions I: Organic and Bio-Organic Chemistry (1995), (11), 1373-9, ISSN: 0300-022X * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP4764009B2 (ja) | 2011-08-31 |
| CA2512346A1 (en) | 2004-07-22 |
| US7772270B2 (en) | 2010-08-10 |
| US20050004166A1 (en) | 2005-01-06 |
| WO2004060874A1 (de) | 2004-07-22 |
| PT1585728E (pt) | 2010-04-20 |
| AU2003300535A1 (en) | 2004-07-29 |
| BR0317894A (pt) | 2005-12-06 |
| ES2341612T3 (es) | 2010-06-23 |
| DK1585728T3 (da) | 2010-06-14 |
| DE50312458D1 (de) | 2010-04-08 |
| ATE458721T1 (de) | 2010-03-15 |
| MXPA05006054A (es) | 2005-08-16 |
| EP1585728B1 (de) | 2010-02-24 |
| JP2006517912A (ja) | 2006-08-03 |
| US20060252752A1 (en) | 2006-11-09 |
| EP1585728A1 (de) | 2005-10-19 |
| IL169496A0 (en) | 2007-07-04 |
| DE10300015A1 (de) | 2004-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007297013B2 (en) | Isoserine derivatives for use as coagulation factor IXa inhibitors | |
| JP4733648B2 (ja) | マトリックスメタロプロテイナーゼ阻害剤としての使用のためのチエノ−イミノ酸誘導体 | |
| CA2504153C (en) | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases | |
| AU2003300535A1 (en) | Imino acid derivatives for use as inhibitors of matrix metalloproteinases | |
| JP4861179B2 (ja) | マトリックスメタロプロテイナーゼの阻害剤として使用される二環式イミノ酸誘導体 | |
| CA2512183A1 (en) | Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors | |
| US7205315B2 (en) | Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases | |
| KR101315788B1 (ko) | 매트릭스 메탈로프로테이나제의 억제제로서 사용하기 위한테트라하이드로푸란 유도체 | |
| US20070155778A1 (en) | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | |
| HK1113367B (en) | Tetrahydrofurane derivatives for use as inhibitors of matrix metalloproteinases | |
| NZ539751A (en) | Pyrimidine-4,6-dicarboxylic acid diamides for the selectively inhibiting collagenase (MMP 13) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH Free format text: FORMER APPLICANT(S): AVENTIS PHARMA DEUTSCHLAND GMBH |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |